Liberty Latin America Ltd.
LILAB
$5.55
-$0.35-5.93%
| Weiss Ratings | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.75 | |||
| Price History | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 21.62% | |||
| 60-Day Total Return | -22.24% | |||
| 90-Day Total Return | -21.88% | |||
| Year to Date Total Return | 21.62% | |||
| 1-Year Total Return | -15.63% | |||
| 2-Year Total Return | -38.64% | |||
| 3-Year Total Return | -25.00% | |||
| 5-Year Total Return | -55.00% | |||
| 52-Week High % Change | -32.50% | |||
| 52-Week Low % Change | 21.62% | |||
| Price | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.00 | |||
| 52-Week Low Price | $5.55 | |||
| 52-Week Low Price (Date) | Dec 20, 2024 | |||
| 52-Week High Price (Date) | Mar 25, 2024 | |||
| Valuation | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.35B | |||
| Enterprise Value | 9.78B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.35 | |||
| Earnings Per Share Growth | 828.68% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.30 | |||
| Price/Book (Q) | 1.18 | |||
| Enterprise Value/Revenue (TTM) | 2.22 | |||
| Price | $6.75 | |||
| Enterprise Value/EBITDA (TTM) | 6.58 | |||
| Enterprise Value/EBIT | 18.47 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 196.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 925 6000 | |||
| Address | -- | |||
| Website | www.lla.com | |||
| Country | Bermuda | |||
| Year Founded | 2017 | |||
| Profitability | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 12.03% | |||
| Profit Margin | -14.74% | |||
| Management Effectiveness | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.54% | |||
| Return on Equity | -- | |||
| Income Statement | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.46B | |||
| Total Revenue (TTM) | 4.46B | |||
| Revenue Per Share | $22.67 | |||
| Gross Profit (TTM) | 3.47B | |||
| EBITDA (TTM) | 1.50B | |||
| EBIT (TTM) | 536.30M | |||
| Net Income (TTM) | -657.00M | |||
| Net Income Avl. to Common (TTM) | -657.00M | |||
| Total Revenue Growth (Q YOY) | -1.14% | |||
| Earnings Growth (Q YOY) | -94.44% | |||
| EPS Diluted (TTM) | -3.35 | |||
| EPS Diluted Growth (Q YOY) | -79.43% | |||
| Balance Sheet | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 735.60M | |||
| Cash Per Share (Q) | $3.74 | |||
| Total Current Assets (Q) | 2.13B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.63B | |||
| Current Ratio (Q) | 1.043 | |||
| Book Value Per Share (Q) | $5.70 | |||
| Total Assets (Q) | 12.80B | |||
| Total Current Liabilities (Q) | 2.04B | |||
| Total Debt (Q) | 8.66B | |||
| Total Liabilities (Q) | 11.17B | |||
| Total Common Equity (Q) | 1.12B | |||
| Cash Flow | LILAB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -688.50M | |||
| Cash from Financing (TTM) | -386.40M | |||
| Net Change in Cash (TTM) | -329.50M | |||
| Levered Free Cash Flow (TTM) | 354.59M | |||
| Cash from Operations (TTM) | 756.30M | |||
